AMAG Related
-
Ferumoxytol Treatment Produced Significant Hemoglobin Increases in Adult Iron Deficiency Anemia Patients With Gastrointestinal Disease Who Had Failed or Could Not Tolerate Oral Iron Therapy
-
Form 4 AMAG PHARMACEUTICALS For: May 14 Filed by: HEIDEN WILLIAM K
-
Ferumoxytol Results in Significant Hemoglobin Increases in Adult Iron Deficiency Anemia Patients With Abnormal Uterine Bleeding Who Had Failed or Could Not Tolerate Oral Iron Therapy
-
Form 10-Q AMAG PHARMACEUTICALS For: Mar 31
-
Form SC 13D/A AMAG PHARMACEUTICALS Filed by: Shkreli Martin
-
AMAG Pharmaceuticals to Present at the Needham Healthcare Conference
-
Form 8-K AMAG PHARMACEUTICALS For: Apr 23
-
AMAG Announces First Quarter 2013 Financial Results
-
AMAG Pharmaceuticals, Inc. to Host Conference Call on April 23, 2013 at 4:30 p.m. ET to Discuss Financial Results for the Quarter Ended March 31, 2013
-
Form 8-K AMAG PHARMACEUTICALS For: Apr 01
-
Leerink Swann Raises PT on AMAG Pharmaceuticals
-
AMAG Pharma (AMAG) Medical Chief Allen to Leave
-
AMAG Pharma (AMAG) Reports Statistically Significant Data from IDA-303
-
AMAG Pharma (AMAG) sNDA for Feraheme Accepted by U.S. FDA
-
JPMorgan Upgrades AMAG Pharmaceuticals (AMAG) to Neutral
-
AMAG Pharmaceuticals, Inc. (AMAG) Misses Q4 EPS by 10c; Reaffirms FY13 Rev Outlook
-
Leerink Swann Upgrades AMAG Pharmaceuticals (AMAG) to Outperform
-
AMAG Pharma (AMAG) Appoints Greg Madison as Commerical Chief
-
AMAG Pharma (AMAG) Submits sNDA for Feraheme to FDA
-
AMAG Pharma (AMAG) Reports Ferumoxytol Met All Primary Endpoints in Two Phase IIIs
-
AMAG Pharma (AMAG) Reports Q3 Loss of 19c/Share; Updates Feraheme Revs Outlook
-
AMAG Pharma (AMAG) Gets Market Authorization for Ferumoxytol from Swissmedic
-
Summer Street Upgrades AMAG Pharmaceuticals (AMAG) to Buy
-
AMAG Pharmaceuticals, Inc. (AMAG) Reports Q2 EPS of $0.15
-
Trading Radar for 07/26: Facebook (FB), Sprint (S), Amazon (AMZN), Starbucks (SBUX), 3M (MMM), Dow (DOW), Potash (POT) Report
-
AMAG Pharma (AMAG) to Reduce Workforce by 45 Spots; Will Focus More on Feraheme Development
-
AMAG Pharma (AMAG) Says Ferumoxytol MAA Granted in Europe; Will Get $15M Milestone
-
AMAG Pharma (AMAG) Shares Rally Sharply Following Ladenburg Upgrade
-
AMAG (AMAG) Shares Collapse as Board Quietly Abandons Active Sale Process
-
Morning Movers 05/10: (ADY) (INSP) (KERX) (CYTX) Higher; (SGI) (CDTI) (ARX) (WFR) Lower
-
Landenburg Thalmann Downgrades AMAG Pharmaceuticals (AMAG) to Hold
-
Baird Downgrades AMAG Pharmaceuticals (AMAG) to Neutral; Stepping To Sidelines As Risk Profile Increases
-
AMAG Pharma (AMAG) Pops Higher on Positive CHMP Opinion for Ferumoxytol
-
AMAG Pharma (AMG) Gets Positive CHMP Opinion for Ferumoxytol
-
Baird Reiterates an 'Outperform' on AMAG Pharmaceuticals (AMAG); Positive IDA Trial De-Risks Major Opportunity
-
Prelim. Results from Phase III Trial on AMAG Pharma's (AMAG) Feraheme Met Primary Endpoints
-
Jefferies Maintains an 'Underperform' AMAG Pharmaceuticals (AMAG); Still Sees Roughly Breakeven for FY12; Ongoing Strategic Review
-
Baird Reiterates an 'Outperform' on AMAG Pharmaceuticals (AMAG); Three Key Reasons to Remain Positive Including Takeout
-
AMAG Pharmaceuticals, Inc. (AMAG) Tops Q4 EPS by 25c
-
Trading Radar for 03/05: VeriFone (PAY), NutriSystem (NTRI), Steinway Musical (LVB), Jiayuan.com (DATE) Report
-
AMAG Pharmaceuticals (AMAG) Adds Rajiv De Silva and Gino Santini to Board
-
JPMorgan Downgraded Several Biotech Stocks (ACOR, ALTH, AMAG, AMGN & VPHM)
-
JPMorgan Downgrades AMAG Pharmaceuticals (AMAG) to Underweight
-
AMAG Pharmaceuticals (AMAG) Offers Q4 Sales Guidance Below Expectations
-
Short Interest Ticks Up in Large-Cap Biotech, Specifically Amgen (AMGN)
-
Goldman Sachs Starts AMAG Pharmaceuticals (AMAG) at Neutral, Agrees with Management's New Plans
-
AMAG Pharma (AMAG), Takeda Get Marketing Approval for Feraheme in Canada
-
AMAG Pharma's (AMAG) Feraheme Met Primary Endpoint in IDA Patients
-
AMAG Pharmaceuticals (AMAG) Reports Preliminary Data for the Safety & Efficacy of Single Infusion of 1020 mg Ferumoxytol
-
Morgan Stanley Resumes AMAG Pharmaceuticals (AMAG) at Equalweight
Back to AMAG Stock Lookup
